Evidence map›Paper›PMID 37611964›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2023

Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin's lymphoma: a case report.

Manjappa Mahadevappa, Kiran Pura Krishnamurthy, Lakshay Kumar Attri, Yogitha Chandrappa, Prashanth Kulkarni

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Manjappa MahadevappaCardiology, JSS Medical College, Mysuru, Karnataka, India manjappam@gmail.com.ORCID 0000-0002-8710-2397
Kiran Pura KrishnamurthyOncology, JSS Medical College, Mysuru, Karnataka, India.
Lakshay Kumar AttriPharmacy Practice, JSS College of Pharmacy, Mysuru, Karnataka, India.ORCID 0000-0002-7627-8039
Yogitha ChandrappaMedicine, JSS Medical College, Mysuru, Karnataka, India.
Prashanth KulkarniCardiology, Heart Care Centre, SVP Nagar, Bidar, Karnataka, India.ORCID 0000-0002-2170-2103
JSS Medical College and Hospital · INJSS Academy of Higher Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthracyclines are associated with cardiotoxic manifestations that are mainly dose-dependent, with onset varying from a few days to many years after stopping treatment. Frequent monitoring for toxic manifestations, early detection, cessation of anthracycline use and appropriate treatment is the key to preventing morbidity and mortality. Complete heart block with doxorubicin use in Hodgkin's lymphoma is rarely reported, and is a severe toxic manifestation necessitating withdrawal or changing of regimen to etoposide + bleomycin + vinblastine + dacarbazine (EBVD), as in this case.

Indexed as

Hodgkin DiseasePolyketidesAnthracyclinesDacarbazineDoxorubicinHeart BlockHumansAnthracyclinesDacarbazineDoxorubicinPolyketidesAntineoplastic agentsCase ReportsDRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONSHeart failureMEDICAL ONCOLOGY

Identifiers

PMID37611964
PMCPMC10447958
OpenAlexW4294316888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.